‘UK Veterinary Vaccinology Network’ Madeleine Clark (The Pirbright Institute, UK)

'International Veterinary Vaccinology Network’ Dr. Timothy Connelley (The Roslin Institute, UK)

‘African Vaccinology Network’ Prof Mustapha Oumouna (University of Medea, Algeria)

Theme 1: Vaccines for Ectoparasites

‘Targeting host-vector-pathogen interactions to reduce the global burden of tick-borne diseases’ Professor Jose de la Fuente (Instituto de Investigaci√≥n en Recursos Cineg√©ticos, Spain)

‘The potential for vaccination to control poultry red mite’ Dr. Alasdair Nisbet (Moredun Research Institute, UK)

‘Sea lice vaccine development’ Professor Frank Nilson (University of Bergen, Norway)

‘SophisTICKated anti-tick vaccines – cattle tick and Australian paralysis tick’ Professor Ala Tabor (University of Queensland, Australia)

‘A decavalent vaccine based on recombinant tick salivary proteins decreases successive infestations with Rhipicephalus microplus in cattle’ Professor Isabel Kinney Ferreira de Miranda Santos (University of Sao Paulo, Brazil)

‘A dual mixture of recombinant tick antigens decrease fecundity in Rhipicephalus appendiculatus under laboratory conditions’ Irene Kiio (International Livestock Research Institute, Kenya)

Theme 2: Vaccine Commercialisation

‘Towards sustainable supply of quality registered veterinary vaccines: the East Africa Community’s Mutual Recognition Procedure’ Dr Lois Muraguri (GALVmed, UK)

‘Technology Licensing: Art or Science?’ Dr. Peter Jeffries (Business Development Adviser, UK)

‘Catalysing demand for livestock vaccines: Gender and youth-specific considerations in adoption of thermostable Newcastle disease vaccine in Eastern Kenya’ Tabby Karanja-Lumumba, (International Development Research Centre (IDRC), Kenya)

‘Elimination of Taenia solium transmission by pigs in a field trial undertaken in Nepal using Cysvax, a commercially manufactured TSOL18 vaccine’ Professor Marshall Lightowlers (The University of Melbourne, Australia)

Theme 3: Antigen Discovery

‘Analyses of the intracellular Proteome of African swine fever virus’ Dr. Axel Karger (Friedrich-Loeffler-Instituts, Germany)

‘Development of a vaccine for contagious bovine pleuropneumonia’ Dr. Volker Gerdts (VIDO-InterVac, Canada)

‘T cell antigen discovery for new vaccination approaches to East Coast Fever’ Dr. Nicola Ternette (University of Oxford, UK)

‘Programmable Animal Vaccines: The Modified Dendrimer-mRNA Platform’ Dr. Omar Khan (Tiba Biotech, USA)

‘Multiple bacterial veterinary pathogens contain phase-variable regulons; phasevarions’ Dr. John Atack (Griffith University, Australia)

‘Exploring the cattle MHCII ligands’ Andressa Fisch (University of Sao Paulo, Brazil)

Theme 4: Controlling AMR with Vaccination

‘Prioritization of animal diseases for which vaccines could reduce antimicrobial use’ Dr. Vish Nene (International Livestock Research Institute, Kenya)

‘Could and should vaccination be used to control antimicrobial use or antimicrobial resistance in animal populations?’ Professor Ruth Zadoks (University of Glasgow, UK)

‘InnoVet-AMR’ Dr. Shahida Syed (Global AMR Innovation Fund (GAMRIF), UK Department of Health and Social Care (DHSC), UK)

‘Dedicated adjuvants for bacterial autogenous vaccines’ Dr. BingLing XU (SEPPIC, France)

Keynote Presentation

'The factors affecting the livelihood of small holder farmers in LMICs’ Dr. Nicoline de Haan (International Livestock Research Institute, Kenya)

Concluding Comments

Professor Gary Entrican (Moredun Research Institute, UK)